#
#
#
|Contents|||||Pacaee|
|---|---|---|---|---|---|
|Reference|and Administrative|||Details ofthe Charity|3 —11|
|Trustee's|Report||||12 —22|
|Statement|ofTrustee's||responsibilities||23|
|Independent
auditor's||report|||24-27|
|Foreword|||||28|
|Statement|of Financial|Activities|||29|
|Balance Sheet|||||30|
|Statement|of Cashflow||||31|
|Statement|ofAccounting||Policies||32-36|
|Notes to the Financial||Statements|||37-48|
##
##
##
|ust Board of Di|rectors (B|oD) holding
office from April 2020 to January|20|22 ar|e:|
|---|---|---|---|---|---|
|Chairman||John Anderson||||
|Chief Executive||Ken Bremner||||
|Executive Directors||Shahid Wahid —Executive Medical Director||||
|||Julia Pattison —Executive
Director of Finance||—to|31|
|||March 2021||||
|||Hayley Wardle —Executive Director of Finance —from||||
|||1 April 2021||||
|||Melanic Johnson —Executive Director of Nursing,||||
|||Midwifery
and Allied Health Professionals||||
|||Peter Sutton —Executive Director of Planning||and||
|||Business Development||||
|||Kath Griffin —Executive Director of Human|Resources|||
|||and Organisational
Development||||
|Trust Secretary/Director||Andrea
Hetherington
—Director of Corporate||Affairs||
|||and
Legal/Trust
Secretary/Freedom
to|Speak||Up|
|||Guardian||||
|Non-Executive|Directors|Stewart Hindmarsh||||
|||David Barnes||||
|||Paul McEldon||||
#
#
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||||||||Combined|
|---|---|---|---|---|---|---|---|---|---|
|||||||||Total|Total|
|||||Notes|Unrestricted|Restricted|Endowment|2021|2020|
||||||Funds|Funds|Funds|Funds|Funds|
||||||f000|EOOO|EOOO|6000|EOOO|
|Income from:||||||||||
|Donations
&Legacies|||||1,565||0|1,567|907|
|Grants||||2.4|258||0|258||
|Charitable
Activities|||||69|||69|77|
|Other Trading|Activities|||||||||
|investments||||9.4|79|||83|gg|
|Total Income|||||1,977||0|1,983|1,090|
|Expenditure
on:||||||||||
|Raising Funds|||||(23)|(1)|0|(24)|(61)|
|Charitable
Activities|||||(726)|(98)|0|(824)|(1,275)|
|Total Ex enditure||||7|(749)|(99)|0|(848)|1 336)|
|Net Gain/(Loss)
on investments||||9.1|388|24|0|412|(224)|
|Net Income) ( Expenditure|||||1,616|(69|0|1,547|(470)|
|Transfer between||funds|||0|0|0|0|0|
|Net movement
in|funds||||1,616|(69)|0|1,547|(470)|
|Reconciliation
of|Funds:|||||||||
|Total funds brought|||forward||5,180|236|159|5,575|6,045|
|Total funds carried forward||||13|6,796|167|159|7&122|5,575|
##
|||||||||Combined|
|---|---|---|---|---|---|---|---|---|
||||||||Total|Total|
||||Notes|Unrestricted|Restricted|Endowment|2021|2020|
|||||Funds|Funds|Funds|Funds|Funds|
|||||EOOO|8000|f000|6000|f000|
|Non current|assets||||||||
|Investments|||9.1,9.3|3,551|161|1|3713|2104|
|Total non-current||assets||3.551|161|1|3713|2104|
|Current assets|||||||||
|Investments|||9.2||||0|1,158|
|Trade and|other|receivables|10|27|||27|32|
|Cash and cash equivalents||||3,367||158|3,531|3,028|
|Total current|assets|||3,394|6|158|3,558|4,218|
|Current liabilities|||||||||
|Trade and|other|payables|12|(149)|0|0|(149)|(747)|
|Net current assets||||3,245|6|158|3,409|3,471|
|Total net assets||||6,796|167|159|7,122|5,575|
|Retained funds of||the Charity|||||||
|Endowment|Funds||13.1|0|0|159|159|159|
|Restricted|Income Funds||13.3|0|167|0|167|238|
|Unrestricted|Income Funds||13.5|6,796|0|0|6,796|5,180|
|Total retained|funds ofthe Charit|||6,796|167|159|7,122|5,575|
##
|||||||Combined|
|---|---|---|---|---|---|---|
|||||||Total|
||||||Year Ended|Year Ended|
||||||31 March 21|31 March 20|
||||||R'000s|6'OOOS|
|Net income and expenditure|for|the reporting||period|1,547|(470)|
|Decrease
in current debtors|||||5|90|
|(Decrease) / Increase
in current||creditors|||(596)|338|
|Net (Gain) / Loss on investments|||||(412)|224|
|Net cash inflow from operating||activities|||542|182|
|Disposals at Sales Proceeds|values||||677|635|
|Acquisitions
at cost|||||(716)|(598)|
|Net Cash flow from investment||activities|||(39)|37|
|Net cash inflow cash and cash||equivalents|||503|219|
|Cash and cash equivalents|at beginning||of|the period|3,028|2,809|
|Cash and cash equivalents|at end ofthe||period||3,531|3,028|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||||||Combined|
|---|---|---|---|---|---|---|---|
|2|||Unrestricted|Restricted|Endowment|Total
2021|Totai
2020|
||||Funds|Funds|Funds|Funds|Funds|
||||f000|f000|f000|f000|f000|
|2.1|Donations|||||||
||Donations|from individuals|160|||162|194|
||Donations|from charities|24|||24|230|
||Corporate|donations|1,265|||1,265|327|
||Non corporate donations||6|||6|25|
||||1455||0|1457|776|
||Analysis
ofdonations|Analysis
ofdonations|from individuals|from individuals|f000|received|Number ofdeposits|Number ofdeposits||
|---|---|---|---|---|---|---|---|---|---|
||||||2021|2020|2021|2020||
||Individuals
giving|&f1k|||38|58|16|24||
||Individuals
giving|&f100|||67|94|211|348||
||Fundraising
-voluntary|||(not via STSFT)|21|22|50|30||
||Other||||36|20|363|254||
||Totals||||162|194|640|656||
||||||||||Combined|
|||||||||Total|Total|
||||||Unrestricted|Restricted|Endowment|2021|2020|
||||||Funds|Funds|Funds|Funds|Funds|
||||||f000|f000|f000|f000|FOOO|
|2.2|Legacies|||||||||
||Rehab and Elderly Medicine||||40|||40|0|
||Medical Specialties||||42|||42|0|
||General
Internal|Medicine|||0|||0|5|
||Ophthalmology||||22|||22|126|
||CardioThoracic
Medicine||||4|||4|0|
||General Purposes||||2|||2|0|
||||||110||0|110|131|
||In total 10legacies were|||received during|2020/21 (2019/20: 4),|||||
|2.3|Total donations|and|legacies||1,565||0|1 567|907|
||||||||Combined|
|---|---|---|---|---|---|---|---|
|||||||Total|Total|
||||Unrestricted|Restricted|Endowment|2021|2020|
||||Funds|Funds|Funds|Funds|Funds|
|2.4|Grants||f000|f000|f000|f000|f000|
||Grants from Charities|||||||
||NHS CT - NHS Charities Together||198||0|198||
||CHSA - Covid19 Healthcare|Support Appeal|60||0|60||
||||258||0|258||
##
||||||||Combined|
|---|---|---|---|---|---|---|---|
|Income from|3|||||Total|Total|
|charitable|||Unrestricted|Restricted|Endowment|2021|2020|
|activities|||Funds|Funds|Funds|Funds|Funds|
||||f000|f000|f000|f000|f000|
|||Course and conference fees|69|||69|77|
|||6 different course types were held (2019/20: 10).||||||
||||||||Combined|
|Income from|4|||||Total|Total|
|other trading|||Unrestricted|Restricted|Endowment|2021|2020|
|activities|||Funds|Funds|Funds|Funds|Funds|
||||f000|f000|f000|f000|f000|
|||Staff lottery||||||
||||6|0|0|6|7|
##
##
|Analysis of|7|||||Investment|Costs of|||Combined|
|---|---|---|---|---|---|---|---|---|---|---|
|total|||||Costs of|Management|Charitable|Governance|Total|Tote I|
|expenditure|||||Fundrsising|Costs|Activities|Costs|2821|2020|
||||||5000|f000|f000|f000|8800|5000|
|||Other|||(3)|0|(647)|0|(650)|(1,137)|
|||Bought-in services||from NHS|(2)|0|(159)|(2)|(163)|(171)|
|||Investment
Broker||fee|0|(18)|0|0|(18)|(18)|
|||Audit|fees - internal|audit|0|0|0|0|0|(3)|
||||provision||||||||
|||Audit|fees - external statutory|||||(17)|(17)|(7)|
||||audit provision||||||||
||||||||806|19|848|1,336|
##
##
|Traded Non C|u|rrent Asse|t Inv|es|tment|s:||||
|---|---|---|---|---|---|---|---|---|---|
||||||||||Combined|
|||||||||Total|Total|
|||||||||2021|2020|
|||||||||f000|f000|
|Managed
Porffolios||||||||||
|Market value at||1 April||||||2,104|2,370|
|Less: Disposals||at Sales Proceeds|||values|||(677)|(635)|
|Add: Acquisitions||at cost||||||716|598|
|Net unrealised|and realised||gain|/|(loss) on sale and revaluation|||427|229|
|Market value at||31 March||||||2570|2 104|
|Fixed Interest Fund||Holding||||||||
|Market value at||1 April||||||1,158||
|Less: Disposals||at Sales Proceeds|||values|||0||
|Add: Acquisitions||at cost||||||0||
|Net unrealised|and realised||gain|/|(loss) on sale and revaluation|||15||
|Market value at||31 March||||||1,143||
|Total non current|asset investments|||||||3,713|2104|
|Historic cost at|31 March-Managed||||Portfolios and Fixed Interest||Holdin|4,139|2,268|
|Traded Current||Asset Investments:||||||||
||||||||||Combined|
|||||||||Total|Total|
|||||||||2021
f000|2020
f000|
|Fixed Interest Fund||Holding||||||||
|Market value at|1 April||||||||1,153|
|Less: Disposals||at Sales Proceeds|||values||||0|
|Add: Acquisitions||at cost|||||||0|
|Net unrealised
and realised|||gain|/ (loss)||on sale and revaluation|||5|
|Market value at|31 March||||||||1,158|
|Historic cost at|31 March Fixed Interest|||||Holding|||1,150|
||||||Combined|
|---|---|---|---|---|---|
||||||Total|
|Traded Non|Current and Current||Asset Investments:|31 March|31 March|
|||||2021|2020|
|||||f000|f000|
|Investments|listed on a rec|nlsed|ck Exchan e|||
|In the UK||||2,091|1,940|
|Outside the UK||||60|71|
|Unlisted
securities||||||
|In the UK||||1,041|973|
|Outside the UK||||521|278|
|Total||||3,713|3,262|
##
|||||||||Combined|
|---|---|---|---|---|---|---|---|---|
|Analysis of|9.4|Total|gross|income:|||Total|Total|
|gross income|||||||2021|2020|
|from|||||||f000|f000|
|investments|||||||||
|||In|t
en|listedonareco|nisedStockExch|n e.|||
|||In|the UK||||65|73|
|||Outside the UK|||||0|0|
|||Unlisted securities:|||||||
|||In|the UK||||11|16|
|||Outside the UK|||||6|5|
|||Investments||in a Common|Deposit Fund||||
|||Current account
/ short term interest|||||||
|||Total|||||83|99|
##
##
##
|NOTES TO|NOTES TO|THE FINANCIAL STATE|THE FINANCIAL STATE|MENTS|(CONT|INU|ED)||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Analysis of||13(Continued)|||||||||||||||||
|Funds|||||||||||||||||||
||||||||Combined||||||||||||
||||||||Total||||||||||||
|Details|of|13.3|Restricted Funds||||Balance|||||||||||Balance|
|material|||||||1 April|Incoming|Resources|||||Gains||on|Gain on|31 March|
|funds|~||||||2020|Resources||Expended
Transfers||||Disposals|||Revaluation|2021|
|Restricted|||||||f000|f000|||f000|f000|||f000||f000|f000|
|Funds|||Material funds||||||||||||||||
||||Eye Infirmary
Legacy||||94||||(94)||||||0|0|
||||Leukaemia
Research|Legacy|||71||||(2)||||||23|97|
||||Orthopaedics
bequest||||35||||0||||||0|35|
||||Neonatal
Unit Legacy||||13||||0||||||0|13|
||||Other designated
funds||||23||||3||||||0|22|
||||Total||||236||||99||8||||23|167|
|||13A|Description offunds||||||||||||||||
||||Eye Infirmary
Legacy|||||For the purchase|||ofmedical|equipment|||||||
||||Leukaemia
Research|Legacy||||For leukaemia||snd lymphoma||research.|||||||
||||Orthopsedics
bequest|||||For the provision|||ofan operating||theatre||bed specifically||||
|||||||||designed for||people suffering||from curvature||||of|the spine||
||||Neonatal
Unit legacy|||||For South Tyneside neonates|||||||||||
||||||||Combined||||||||||||
|Details|of|13.5|Unrestricted
Funds||||Total||||||||||||
|material|||||||Balance|||||||||||Balance|
|funds-|||||||1 April|Incoming|Resources|||||Net|Gain|on|Net Gain on|31 March|
|Unrestricted|||||||2020|Resources||Expended
Transfers||||Disposals|||Revaluation|2021|
|Funds|||||||f000|f000|||f000|f000|||f000||f000|6000|
||||Material funds||||||||||||||||
||||Medical Equipment|purposes|||672|1,013|||(80)|||||13||1,618|
||||CO)/ID 19||||0|548|||(20)|||||6||536|
||||General
Purposes||||538|34|||(152)|||||10||430|
||||Paediatric department||||321|11|||(3)|||||6||335|
||||NeoNatal
Unit||||301|16|||(8)|||||6||315|
||||Rise Above Cancer||||185|38|||(46)|||||4||181|
||||SRH Coronary
Care||||160|6|||(2)|||||3||167|
||||Glaucoma
purposes||||182|5|||(37)|||||3||153|
||||Maternity
Unit||||162|3|||(30)|||||3||138|
||||Clinical Haematology||||152|25|||(56)|||||2||123|
||||Phoenix
Unit
— Chemotherapy||||107|24|||(22)|||||2||111|
||||SEIGeneral
Purposes||||170|29|||(97)|||||2||104|
||||Diabetes purposes|Legacy|||87|1|||(1)|||||2||89|
||||SRH Ward D46 Strake ( prev ESS,D41)||||53|44|||(10)|||||2||89|
||||Orthopaedic
Department||||125|2|||(43)|||||2||86|
||||Elderly Mediine
Wards||||78|1|||(6)|||||2||75|
||||Pharmacy
department||||67|8|||(I)|||||1||75|
||||Renal purposes||||43|31|||(1)|||||1||74|
||||MS fund||||91|1|||(27)|||||2||67|
||||STDH Cardiology
bequests||||63|I|||(1)|||||2||65|
||||Staff Lottery||||62|12|||(12)|||||0||62|
||||ENT/SALT purposes||||57|4|||(1)|||||1||61|
||||Diagnostic Imaging|department|||65|1|||(7)|||||1||60|
||||South Tyneside
Community||Planned|Car|50|7|||0|||||1||58|
||||SRH Cardiology||||55|2|||(1)|||||1||57|
||||Gynsecology
purposes||||53|1|||(1)|||||1||54|
||||Thoracic Medicine||||45|5|||(1)|||||1||50|
||||Other||||1236|104|||(83)|||||0|306|1,563|
||||Total Unrestricted|Funds|||5,180|1 977|||||0|||82|306|8,796|
|Medical
Equipment
purposes|Larger items of medical equipment
funded from CHolCE donations.|Larger items of medical equipment
funded from CHolCE donations.|Larger items of medical equipment
funded from CHolCE donations.|Larger items of medical equipment
funded from CHolCE donations.|
|---|---|---|---|---|
|(incl CHoICE donation)|||||
|COVID 19|Trustwide
in accordance
with the objects ofthe||Charity and conditions||
||set by NHS Charities Together (incl Captain
Sir Tom Moore distributions).||||
|General
Purposes|Trustwide
in accordance
with the objects ofthe||Charity.||
|Paediatric
department|Equipment
and patient amenities across Paediatrics||||
|NeoNatal
Unit|Equipment
and patient amenities
for the Neonates
service||||
|Rise Above Cancer|Information,
support and complimentary|therapy|treatment
rooms on||
|formerly Cancer Support - Macmillan|Sunderland
Royal and South Tyneside|District hospital sites|||
|SRH Coronary
Care|Equipment,
patient amenities,
training|within the Unit.|||
|Glaucoma
purposes|Incorporating
the GRADERS
fund, for glaucoma||service purposes||
||including
research
and development||||
|Maternity
Unit|Equipment
for the maternity
unit and purposes||in accordance|with the|
||objects ofthe Charity||||
|GRAD@S|Glaucoma research
and development|in Sunderland.|||
|Coronary Care Unit|For expenditure
in accordance
with the|objects|ofthe Charity.||
|Clinical Haematology|Equipment,
education
and patient care|in Clinical Haematology.|||
|(formerly called Blood Disorders)|||||
|Phoenix
Unit - Chemotherapy|Equipment
and patient amenities
within|the Unit - relocated|||
|SEIGeneral
Purposes|For Eye Infirmary
benefit
in accordance|with the objects ofthe||Charity.|
|Diabetes purposes
Legacy|For expenditure
in accordance
with the|objects|ofthe Charity.||
|SRH Ward D45 Stroke|Equipment
and patient amenities
within|the ward|||
|(previously
located on ward E58)|||||
|Orthopaedic
Department|Equipment,
training
and education
within the department.||||
|Elderly Mediine Wards|For expenditure
in accordance
with the|objects|ofthe Charity.||
|Pharmacy
department|Equipment,
training
and education
within the department.||||
|Renal purposes|For expenditure
in accordance
with the|objects|ofthe Charity.||
|MS fund|To develop
Multiple Sclerosis services.||||
|STDH Cardiology
bequests|For expenditure
in accordance
with the|objects|ofthe Charity.||
|Staff Lottery|Staff lottery draw - to benefit STSFThealthcare||provision.||
|(formerly
District Lottery Suspense)|||||
|ENT/SALT purposes|For purposes
including
Head and Neck cancer||services||
|Diagnostic
Imaging
departmen|Relating
to Radiology and Medical Physics.||||
|South Tyneside
Community|For expenditure
in accordance
with the|objects|ofthe Charity.||
|Planned
Care|||||
|SRH Cardiology|For expenditure
in accordance
with the|objects|ofthe Charity.||
|Gynaecology
purposes|For expenditure
in accordance
with the|objects|ofthe Charity.||
|Thoracic Medicine|For expenditure
in accordance
with the|objects|ofthe Charity.||
##
##
##
##
##
##
##
##
|||||||||||||||Combined|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||||||Charitable|
||||||City|Hospitals||Sunderland|||South Tyneside|||Funds|
||||||||||Total||||Tote I|Total|
|||||Unrestricted|Restricted||Endowment||2019/20|Unrestricted|Restricted|Endowment|2019/20|2019/20|
|||||Funds||Funds||Funds|Funds|Funds|Funds|Funds|Funds|Fuiiila|
|||||f000||EOOO||EOOO|EOOO|EOOO|EOOO|EOOO|f000|EOOO|
|Income from.|||||||||||||||
|Doiistioiia|&Legacies|||869||||0|871|36|0|0|36|907|
|Charitable|Activities|||75||||0|75|2|0|0|2|77|
|Other Trading Activities|||||||||||||||
|Investments||||54|||||59|37|||40|99|
|Tots I Income||||1,005|0|6||I|1,012|75|3|0|70|1,090|
|Expenditure
on:|||||||||||||||
|Raising Funds||||(60)||(I)||0|(61)|0|0|0|0|(61)|
|Charitable|Activities|||(1,156)||(1)||0|(1,157)|(117)|(I)|0|(118)|(1,276)|
|Total Ea
dlture||||(1,216)||(2)||0|(1,218)|(11|(1)|0|118)|(1,336)|
|Net (Loss)l Gain on Investments||||(214)||(15)||0|(229)|5|0|0|5|(224)|
|Net (EspeitdHure)l|Income|||)425)||11)||I|(435)|(37)|2|0|35)|(470)|
|Transfer between||funds||0||I||(I)|0|0|0|0|0||
|Nel movement
In hinds||||(425)||(10)||0|(435)|(37)|2|0|(35)|(470)|
|Reconciliation
of Funds:|||||||||||||||
|Total funda|brought||forward|4,345||179||159|4,682|1,295|67|I|1,363|s,o45|
|Total funds carried|forward|||3,920||160||159|4,247|1,250||I|1,320|5,575|
##
|||||||||||Combined|
|---|---|---|---|---|---|---|---|---|---|---|
|||||||||||Charitable|
||||City Hospitals|Sunderlsnd|||South|Tyneside||Funds|
||||||Total||||Total|Total|
|||Unrestricted|Restricted Endowment||2019/20|Unrestricted|Restricted|Endowment|2019I20|2019I2D|
|||Funds|Funds|Funds|Funds|Funds|Funds|Funds|Funds|Funds|
|||f000|EDOO|EODO|8000|EOOD|EOOD|EOOD|8000|EDOD|
|Non current assets|||||||||||
|Investments||1,988|118|0|2,104|0|0|0|0|2,1IN|
|Total non-current|assets|1,986|116|0|2,104|0|0|0|0|2,104|
|Current assets|||||||||||
|Investments||||||1132|25|I|1158|1,158|
|Trade and other receivables||20|0|0|20|12|0|0|12|32|
|Cash and cash e urvalents||2,494|52|159|2,705|27r|46||||
|Total current assets||2,514|52|159|2,725|1,421|71|1|1,493|4,218|
|Current
liabilities|||||||||||
|Trade and other payablea||(582)|0|0|(582)|(163)|(2)|0|(165)|R47)|
|Net current assets||1.932|52|159|2,143|1,258|69||||
|Total net assets||392D|188|159|4247|1 258|69||||
|Retained funds of|tha Charity||||||||||
|Endowment
Funds||D|0|159|159|0|0|I|1|160|
|Restricted
Income Funds||0|168|0|169|0|69|0|69|23'I|
|Unrestricted
Income|Funds|3.920|0|0|3,920|1,258|0|0|1,258|5,178|
|Total retained
funds||3,920|168|159|4,247|1,258|69|1|||